We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
-4.98%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$66.2M
AUM Growth
-$4.96M
Cap. Flow
+$13.4M
Cap. Flow %
20.26%
Top 10 Hldgs %
43.96%
Holding
112
New
26
Increased
20
Reduced
20
Closed
42

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$3.62M
2
PFE icon
Pfizer
PFE
+$3.09M
3
GILD icon
Gilead Sciences
GILD
+$2.52M
4
UNH icon
UnitedHealth
UNH
+$2.44M
5
LLY icon
Eli Lilly
LLY
+$1.85M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$1.61M
2
THC icon
Tenet Healthcare
THC
+$1.3M
3
AAPL icon
Apple
AAPL
+$1.26M
4
BRCM
BROADCOM CORP CL-A
BRCM
+$1.13M
5
LBTYK icon
Liberty Global Class C
LBTYK
+$1.13M

Sector Composition

Rank Sector Weight
1 Healthcare 61.28%
2 Communication Services 5.62%
3 Financials 5.54%
4 Technology 4.38%
5 Consumer Discretionary 4.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VAR
101
DELISTED
Varian Medical Systems, Inc.
VAR
– –
-8,476
Closed -$627K
ONCE
102
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-1,859
Closed -$112K
MSCC
103
DELISTED
Microsemi Corp
MSCC
– –
-935
Closed -$33K
JUNO
104
DELISTED
Juno Therapeutics, Inc.
JUNO
– –
-10,194
Closed -$544K
EXAR
105
DELISTED
Exar Corporation
EXAR
– –
-850
Closed -$8K
ISIL
106
DELISTED
Intersil Corp
ISIL
– –
-2,068
Closed -$26K
PGND
107
DELISTED
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
– –
-5,740
Closed -$165K
ATML
108
DELISTED
ATMEL CORP
ATML
– –
-16,050
Closed -$158K
ZSPH
109
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
– –
-10,059
Closed -$527K
KYTH
110
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
– –
-10,098
Closed -$760K
OREX
111
DELISTED
Orexigen Therapeutics, Inc.
OREX
– –
-12,735
Closed -$630K
1 2 3 4
5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q3 2015 Portfolio in Review

As of Q3 2015, Partner Investment Management held 112 positions worth $66.2M, down 7% from $71.1M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Partner Investment Management deployed $13.4M of net new capital in Q3 2015, opening 26 new positions and adding to 20 existing holdings. Its largest new stake was Allergan plc: 11,785 shares worth $3.2M.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 50% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was BROADCOM CORP CL-A, an estimated $1.13M trimmed.

  • Partner Investment Management's largest Q3 2015 buy was Allergan plc: 11,785 shares worth $3.2M.
  • Partner Investment Management added most to UnitedHealth in Q3 2015, an estimated $2.44M increase.
  • Partner Investment Management's biggest Q3 2015 reduction was BROADCOM CORP CL-A, cutting an estimated $1.13M.
  • Partner Investment Management fully exited Elevance Health in Q3 2015, selling an estimated $1.61M.
  • Partner Investment Management's ten largest holdings make up 44% of its $66.2M portfolio in Q3 2015.
  • Partner Investment Management opened 26 new positions and closed 42 in Q3 2015.
  • Partner Investment Management's portfolio value fell 7% quarter-over-quarter to $66.2M.

Based on Partner Investment Management's 13F filing for Q3 2015, filed 16 Nov 2015.